Home › Funds › Verus Financial Partners, Inc. › JNJ

Verus Financial Partners, Inc. position in JNJ

JOHNSON & JOHNSON · Health Care

Verus Financial Partners, Inc. reported holding 4,494 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.10% of its reported portfolio and ranking #46 among its reported holdings. Verus Financial Partners, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.49K sh
Reported value held$1.19M
Portfolio Weight0.10%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Verus Financial Partners, Inc.'s JNJ position evolved

Verus Financial Partners, Inc. first disclosed a stake in JNJ in Q3 2023 at 4,791 shares (US$752K). The position peaked in Q3 2026 at 4,494 shares, worth US$1.2M. Across 13 filings, Verus Financial Partners, Inc. increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,494 shares valued at US$1.2M — an increase of 41 shares quarter over quarter.. Notable position changes include a 26% increase in Q3 2025 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.79K $751.54K New
Q4 2023 4.82K $768.68K Add
Q1 2024 4.58K $725.04K Reduce
Q2 2024 4.52K $660.28K Reduce
Q3 2024 4.33K $701.67K Reduce
Q4 2024 4.00K $568.34K Reduce
Q1 2025 4.28K $656.83K Add
Q2 2025 4.17K $651.34K Reduce
Q3 2025 5.27K $976.93K Add
Q4 2025 4.69K $1.04M Reduce
Q1 2026 4.92K $1.15M Add
Q2 2026 4.45K $1.13M Reduce
Q3 2026 4.49K $1.19M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Verus Financial Partners, Inc. held JNJ?

Verus Financial Partners, Inc. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Verus Financial Partners, Inc.'s current position in JNJ?

As of Q3 2026, Verus Financial Partners, Inc. holds 4.49K shares of JNJ (JOHNSON & JOHNSON), valued at $1.19M, representing 0.10% of its reported portfolio and ranking #46.

Has Verus Financial Partners, Inc. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Verus Financial Partners, Inc. increased its position in JNJ. The position peaked in Q3 2026 at 4.49K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.